Longitude Capital Partners Ii, Llc - Net Worth and Insider Trading

Longitude Capital Partners Ii, Llc Net Worth

The estimated net worth of Longitude Capital Partners Ii, Llc is at least $331 Million dollars as of 2024-11-13. Longitude Capital Partners Ii, Llc is the 10% Owner of Aimmune Therapeutics Inc and owns about 7,513,134 shares of Aimmune Therapeutics Inc (AIMT) stock worth over $259 Million. Longitude Capital Partners Ii, Llc is the 10% Owner of Spot Mobile International Ltd and owns about 3,557,952 shares of Spot Mobile International Ltd (RPID) stock worth over $71 Million. Longitude Capital Partners Ii, Llc is also the 10% Owner of Kala Bio Inc and owns about 45,419 shares of Kala Bio Inc (KALA) stock worth over $324,065. Besides these, Longitude Capital Partners Ii, Llc also holds Aptinyx Inc (APTX) , Tricida Inc (TCDAQ) . Details can be seen in Longitude Capital Partners Ii, Llc's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Longitude Capital Partners Ii, Llc has not made any transactions after 2021-07-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Longitude Capital Partners Ii, Llc

To

Longitude Capital Partners Ii, Llc Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Longitude Capital Partners Ii, Llc owns 7 companies in total, including Vaxcyte Inc (PCVX) , Venus Concept Inc (VERO) , and Tricida Inc (TCDAQ) among others .

Click here to see the complete history of Longitude Capital Partners Ii, Llc’s form 4 insider trades.

Insider Ownership Summary of Longitude Capital Partners Ii, Llc

Ticker Comapny Transaction Date Type of Owner
PCVX Vaxcyte Inc 2020-06-11 10 percent owner
VERO Venus Concept Inc 2019-11-07 10 percent owner
TCDAQ Tricida Inc 2018-07-02 10 percent owner
LIMIT LIMIT 2018-06-25 10 percent owner
LIMIT LIMIT 2017-07-25 10 percent owner
LIMIT LIMIT 2016-11-29 10 percent owner
LIMIT LIMIT 2021-07-19 10 percent owner

Longitude Capital Partners Ii, Llc Latest Holdings Summary

Longitude Capital Partners Ii, Llc currently owns a total of 5 stocks. Among these stocks, Longitude Capital Partners Ii, Llc owns 7,513,134 shares of Aimmune Therapeutics Inc (AIMT) as of March 29, 2016, with a value of $259 Million and a weighting of 78.38%. Longitude Capital Partners Ii, Llc owns 3,557,952 shares of Spot Mobile International Ltd (RPID) as of July 19, 2021, with a value of $71 Million and a weighting of 21.43%. Longitude Capital Partners Ii, Llc also owns 45,419 shares of Kala Bio Inc (KALA) as of July 25, 2017, with a value of $324,065 and a weighting of 0.1%. The other 2 stocks Aptinyx Inc (APTX) , Tricida Inc (TCDAQ) have a combined weighting of 0.09% among all his current holdings.

Latest Holdings of Longitude Capital Partners Ii, Llc

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AIMT Aimmune Therapeutics Inc 2016-03-29 7,513,134 34.49 259,127,992
RPID Spot Mobile International Ltd 2021-07-19 3,557,952 19.91 70,838,824
KALA Kala Bio Inc 2017-07-25 45,419 7.14 324,065
APTX Aptinyx Inc 2018-06-25 3,190,079 0.10 306,248
TCDAQ Tricida Inc 2018-07-02 5,907,889 0.00 59

Holding Weightings of Longitude Capital Partners Ii, Llc


Longitude Capital Partners Ii, Llc Form 4 Trading Tracker

According to the SEC Form 4 filings, Longitude Capital Partners Ii, Llc has made a total of 0 transactions in Aimmune Therapeutics Inc (AIMT) over the past 5 years. The most-recent trade in Aimmune Therapeutics Inc is the acquisition of 78,504 shares on March 29, 2016, which cost Longitude Capital Partners Ii, Llc around $1 Million.

According to the SEC Form 4 filings, Longitude Capital Partners Ii, Llc has made a total of 1 transactions in Spot Mobile International Ltd (RPID) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Spot Mobile International Ltd is the acquisition of 150,000 shares on July 19, 2021, which cost Longitude Capital Partners Ii, Llc around $3 Million.

According to the SEC Form 4 filings, Longitude Capital Partners Ii, Llc has made a total of 0 transactions in Kala Bio Inc (KALA) over the past 5 years. The most-recent trade in Kala Bio Inc is the acquisition of 4,300 shares on July 25, 2017, which cost Longitude Capital Partners Ii, Llc around $3 Million.

More details on Longitude Capital Partners Ii, Llc's insider transactions can be found in the Insider Trading History of Longitude Capital Partners Ii, Llc table.

Insider Trading History of Longitude Capital Partners Ii, Llc

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Longitude Capital Partners Ii, Llc Trading Performance

GuruFocus tracks the stock performance after each of Longitude Capital Partners Ii, Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Longitude Capital Partners Ii, Llc is -3.59%. GuruFocus also compares Longitude Capital Partners Ii, Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Longitude Capital Partners Ii, Llc within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Longitude Capital Partners Ii, Llc's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Longitude Capital Partners Ii, Llc

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -1.06 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -1.39 LIMIT LIMIT LIMIT LIMIT LIMIT

Longitude Capital Partners Ii, Llc Ownership Network

Ownership Network List of Longitude Capital Partners Ii, Llc

No Data

Ownership Network Relation of Longitude Capital Partners Ii, Llc

Insider Network Chart

Longitude Capital Partners Ii, Llc Owned Company Details

What does Vaxcyte Inc do?

Who are the key executives at Vaxcyte Inc?

Longitude Capital Partners Ii, Llc is the 10 percent owner of Vaxcyte Inc. Other key executives at Vaxcyte Inc include director & President & CEO Grant Pickering , SVP & Gen Counsel & Corp Sec Mikhail Eydelman , and Chief Operating Officer Jim Wassil .

Vaxcyte Inc (PCVX) Insider Trades Summary

Over the past 18 months, Longitude Capital Partners Ii, Llc made no insider transaction in Vaxcyte Inc (PCVX). Other recent insider transactions involving Vaxcyte Inc (PCVX) include a net sale of 270,632 shares made by Grant Pickering , a net sale of 152,000 shares made by Andrew Guggenhime , and a net sale of 66,000 shares made by Jim Wassil .

In summary, during the past 3 months, insiders sold 216,881 shares of Vaxcyte Inc (PCVX) in total and bought 0 shares, with a net sale of 216,881 shares. During the past 18 months, 605,929 shares of Vaxcyte Inc (PCVX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 605,929 shares.

Vaxcyte Inc (PCVX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Vaxcyte Inc Insider Transactions

No Available Data

Longitude Capital Partners Ii, Llc Mailing Address

Above is the net worth, insider trading, and ownership report for Longitude Capital Partners Ii, Llc. You might contact Longitude Capital Partners Ii, Llc via mailing address: 800 El Camino Real, Suite 220, Menlo Park Ca 94025.